What You Ought to Know:
– GeneDx, a pacesetter in genomic insights, has introduced the launch of GeneDx Uncover, a groundbreaking information visualization device designed to revolutionize drug discovery and growth.
– The platform offers biopharmaceutical corporations with entry to de-identified and aggregated genetic information, empowering them to speed up the event of recent therapies.
Addressing the Challenges of Drug Improvement
The standard drug growth course of is prolonged, expensive, and infrequently unsuccessful. On common, it takes 12 years and $2.6 billion to carry a brand new drug to market, with a 90% failure fee. GeneDx Uncover goals to deal with these challenges by leveraging the ability of genetic information to enhance decision-making and speed up the event timeline.
Unlocking the Potential of Genetic Knowledge
GeneDx Uncover offers biopharmaceutical corporations with:
- Entry to an unlimited dataset: Leverages GeneDx’s industry-leading database of over 700,000 scientific exomes and genomes.
- Self-service information exploration: Presents an easy-to-use interface for exploring and analyzing genetic information.
- Deeper understanding of affected person populations: Supplies insights into illness prevalence, phenotypic info, and variant-level particulars.
- Enhanced decision-making: Permits data-driven selections all through the drug growth course of.
- Accelerated growth timelines: Helps establish promising drug candidates and streamline scientific trials.
GeneDx Uncover is the most recent addition to GeneDx’s portfolio of options geared toward bettering well being outcomes by genomic insights. The corporate is dedicated to collaborating with biopharmaceutical corporations to speed up drug growth, broaden entry to genetic testing, and in the end enhance affected person care.
